Growing Need for Companion Diagnostics is Evident at Drug Discovery Event
The momentum for targeted therapies has downstream implications for clinical laboratories
Already a member? Log in here
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
What the $1b Roche-PathAI Deal Can Tell Clinical Lab Directors
Roche acquires a workflow rather than a company, says AI industry observer
Already a member? Log in here
Diagnostics Pipeline: Expanded DPYD Test Anticipated to Make Chemotherapy Safer
Labcorp’s new genotyping test can identify gene variants that may make standard oncologic treatment deadly for some
Already a member? Log in here
Diagnostics Pipeline: To Gain Insight into Haystack MRD Test, Quest Works with City of Hope
New liquid biopsy assay will be used in conjunction with 500 cancer patients currently enrolled in clinical trials
Already a member? Log in here
Quest Diagnostics Launches Consumer-Facing AI on Its App and Portal
The company’s patients can use AI to look at trends going back five years
Already a member? Log in here
Thermo Fisher Scientific Debuts Pharmacogenetic Test to Improve Transplant Safety
Proper dosing helps prevent potential side effects such as developing diabetes and kidney damage
Already a member? Log in here
GRAIL’s Moves with MCED Test Illustrate Direct-to-Consumer Surge
By partnering with Hims & Hers and Epic, GRAIL bypasses traditional lab test arrangement
Already a member? Log in here
GNPC identifies subset of proteins elevated across Alzheimer’s and Parkinson’s
Consortium hosts large proteomics dataset for neurodegenerative diseases
Already a member? Log in here
Quest Introduces Myeloma Test That Eliminates the Need for Bone Marrow Biopsies
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
Already a member? Log in here
ClearNote Health Launches Early Detection Test for Pancreatic Cancer
The test offers a 76 percent sensitivity to detection of stage 1 and stage 2 pancreatic cancers
Already a member? Log in here
Turning Physics into a Diagnostic Signal for Bladder Cancer
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures
Already a member? Log in here
Diagnostics Pipeline: NeuroQure Launches Test for Early Autism Diagnosis
The skin-based test can be used on children as young as two days old
Already a member? Log in here
How Labs Can Lead in Early Detection of Infectious Diseases
Smarter operations, automation, and collaboration can strengthen laboratories’ role in early detection
Already a member? Log in here
